U.S. Computed Tomography (CT) Market Size, Share & Forecast 2026–2032

ID: MR-11121 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Computed Tomography (CT)
  • ✓Market Size 2024: USD 2.4 billion
  • ✓Market Size 2032: USD 3.1 billion
  • ✓CAGR: 3.4%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Photon-counting reshapes premium tier: Siemens Healthineers' NAEOTOM Alpha, FDA-cleared in 2021, has forced GE HealthCare and Canon to accelerate photon-counting roadmaps. Health systems now treat dose reduction and spectral data as purchase criteria rather than optional upgrades.
FINDING 02
Chinese OEMs entering mid-range: Many assume Chinese OEMs remain locked out of U.S. CT by tariffs and FDA scrutiny. United Imaging's U.S. subsidiary is winning academic and community hospital bids, and its lower-priced mid-range scanners will compress pricing before 2028.
ANALYST RECOMMENDATION

Analyst Recommendation — Lock service-linked contracts now: Hospital buyers should negotiate five-year service-plus-equipment contracts with GE HealthCare or Siemens Healthineers before Q4 2026, locking in current pricing ahead of tariff-driven list increases. Independent imaging networks should prioritize photon-counting-ready platforms at their next replacement cycle.

Competitive Overview of U.S. Computed Tomography

The U.S. CT market is moderately concentrated, with GE HealthCare, Siemens Healthineers, and Canon Medical Systems USA together controlling most installed systems in hospitals and large outpatient networks. Domestic champion GE HealthCare holds the broadest installed base, supported by its Waukesha, Wisconsin manufacturing footprint and a national field service organization. International rivals Siemens Healthineers and Philips compete mainly on photon-counting capability and premium workflow software.

The domestic-versus-international split is less clear-cut than in most imaging categories because U.S. buyers source components, software, and refurbished systems from abroad. Chinese manufacturer United Imaging Healthcare and Canon Medical, which acquired Toshiba's imaging business, have gained share in community hospitals and academic centers. Competitive advantage in this country depends on service uptime, FDA 510(k) clearance speed, and the ability to bundle AI reconstruction with installation contracts.

Demand Drivers Shaping CT Imaging in the U.S.

Demand is anchored by an aging population and rising oncology and cardiovascular imaging volumes, which keep scanner utilization high across hospital networks. Health systems replacing aging 64-slice fleets favor GE HealthCare and Siemens Healthineers, whose installed-base upgrade programs capture replacement budgets before competitors can win first-time placements. Their service contracts also lock in multi-year utilization data that rivals struggle to displace.

Expanded coverage for coronary CT angiography and stroke protocols in emergency departments has moved cardiac and neuro scanning into standard community hospital workflows. Canon Medical and Philips gain most because their cardiac-optimized platforms, paired with AI triage from partners such as Aidoc, let smaller hospitals meet rapid-read requirements without adding radiologists. Mobile and outpatient imaging operators, meanwhile, favor leased and refurbished systems, benefiting Agiliti and independent service providers.

Competitive Restraints and Market Challenges

Price competition is intensifying as commercial payer rates and Medicare reimbursement for advanced imaging flatten, pushing hospital purchasers to demand lower per-scan capital costs. Refurbished-equipment brokers and Chinese vendors compress mid-range list prices, forcing GE HealthCare and Siemens Healthineers to offer aggressive financing and service bundles that steadily erode hardware margins. Vendors without national field service coverage struggle to match these packages.

Compliance costs and workforce gaps further constrain competition. Facilities must satisfy FDA radiation performance standards under 21 CFR 1020.33 along with accreditation requirements from the American College of Radiology, adding documentation and testing expenses for every installed scanner. Shortages of registered radiologic technologists and biomedical engineers slow installations, favoring vendors with dense regional service networks over challengers with lower-cost hardware.

Growth Opportunities for Market Players

AI-enabled workflow software represents the largest adjacent opportunity. Vendors that bundle reconstruction and triage algorithms with scanner sales, including Siemens Healthineers and GE HealthCare, can convert hardware contracts into recurring software revenue. Independent software companies such as Aidoc and Viz.ai compete for the same emergency and stroke-protocol budgets, creating partnership opportunities for OEMs lacking in-house algorithm depth.

Rural and critical access hospitals represent underserved demand, particularly as federal programs fund telehealth-linked imaging networks. Mobile CT fleets, leased by providers such as Agiliti, let these facilities access advanced scanning without capital outlay. Photon-counting upgrades at academic medical centers also create a replacement cycle favoring Siemens Healthineers, whose NAEOTOM Alpha platform is positioned as the reference system in high-volume centers.

Market at a Glance

MetricU.S. Computed Tomography (CT) Market
Market Size 2024USD 2.4 billion
Market Size 2032USD 3.1 billion
Growth Rate (CAGR)3.4%
Most Critical Decision FactorTotal cost of ownership including service uptime
Largest RegionSouth Region (Texas, Florida, Georgia)
Competitive StructureModerately concentrated; top three OEMs hold most hospital installations

Leading Market Participants

  • GE HealthCare
  • Siemens Healthineers
  • Canon Medical Systems USA
  • Philips Healthcare
  • United Imaging Healthcare
  • Neusoft Medical Systems
  • Shimadzu Medical Systems USA
  • Fujifilm Healthcare Americas
  • Agiliti
  • Aidoc

Regulatory and Policy Environment

The FDA's Center for Devices and Radiological Health regulates CT scanners through premarket 510(k) clearance and enforces radiation performance standards under 21 CFR 1020.33. Clearance timelines shape competitive entry, and the agency's clearance of Siemens Healthineers' photon-counting NAEOTOM Alpha set the dose and spectral benchmark that rivals must match. Section 301 tariffs on Chinese-origin medical devices raise landed costs for United Imaging systems, partially offsetting its price advantage.

CMS policy determines purchasing economics. The Medicare Physician Fee Schedule and the Hospital Outpatient Prospective Payment System set reimbursement for advanced imaging, which governs how quickly providers replace scanners. State Certificate of Need laws in states such as New York and Massachusetts limit new scanner installations, protecting incumbent imaging centers and shaping where OEMs can expand.

Competitive Outlook for U.S. CT Imaging

By 2032, the U.S. CT market will consolidate around a small number of OEMs with photon-counting platforms and AI-integrated service ecosystems. GE HealthCare and Siemens Healthineers are positioned to retain premium hospital share, while Canon Medical and Philips defend mid-range installed bases against Chinese price pressure. Software and service revenues will rise as a share of total vendor income, shifting competition away from hardware pricing.

Independent service organizations and leasing specialists will gain share among ambulatory and mobile imaging buyers, particularly as reimbursement pressure limits capital expenditure. Market entry by Chinese vendors will remain constrained by tariffs and FDA review timelines, but their presence in community hospitals will strengthen, setting a pricing floor that incumbents must meet across the mid-range tier.

Frequently Asked Questions

GE HealthCare and Siemens Healthineers hold the largest installed bases, followed by Canon Medical Systems USA and Philips. United Imaging is the fastest-growing challenger in mid-range scanners.
The market is moderately concentrated, with the top three OEMs controlling most hospital installations. Independent service organizations and refurbished-equipment brokers hold significant share in ambulatory and mobile segments.
United Imaging competes through a U.S. subsidiary and mid-range scanners despite tariffs and FDA review. Its share is growing in community and academic hospitals.
Service network density, AI workflow integration, and FDA clearance speed matter most. Financing flexibility is increasingly decisive in hospital purchasing.
Siemens Healthineers leads with the NAEOTOM Alpha platform. GE HealthCare and Canon are accelerating their own photon-counting programs to avoid losing premium placements.

Market Segmentation

By Product Type
  • Stationary Multi-Slice CT
  • Mobile and Portable CT
  • Photon-Counting CT
  • Dual-Energy CT
By End User
  • Hospitals
  • Ambulatory Surgical and Imaging Centers
  • Diagnostic Imaging Centers
  • Veterans Health Administration
By Application
  • Oncology
  • Cardiology
  • Neurology
  • Trauma and Emergency Medicine

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Computed Tomography - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Product Type Insights
4.1 Stationary Multi-Slice CT
4.2 Mobile and Portable CT
4.3 Photon-Counting CT
4.4 Dual-Energy CT
4.5 Others
Chapter 05 End User Insights
5.1 Hospitals
5.2 Ambulatory Surgical and Imaging Centers
5.3 Diagnostic Imaging Centers
5.4 Veterans Health Administration
5.5 Others
Chapter 06 Application Insights
6.1 Oncology
6.2 Cardiology
6.3 Neurology
6.4 Trauma and Emergency Medicine
6.5 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 GE HealthCare
7.2.2 Siemens Healthineers
7.2.3 Canon Medical Systems USA
7.2.4 Philips Healthcare
7.2.5 United Imaging Healthcare
7.2.6 Neusoft Medical Systems
7.2.7 Shimadzu Medical Systems USA
7.2.8 Fujifilm Healthcare Americas
7.2.9 Agiliti
7.2.10 Aidoc
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.